Literature DB >> 17716598

Sleep and breathing in multiple system atrophy.

Alex Iranzo1.   

Abstract

Sleep disorders are common manifestations in multiple system atrophy (MSA) and include reduced and fragmented sleep, excessive daytime sleepiness, rapid eye movement (REM) sleep behavior disorder (RBD), stridor, and sleep-disordered breathing. RBD and nocturnal stridor are considered red flags and may be the first symptoms of the disease. RBD occurs in 90% to 100% of the patients, indicating severe and widespread pathologic impairment in the brain structures that regulate REM sleep. In 50% of the patients, RBD precedes the onset of waking motor symptoms and autonomic failure by several years. Sleep-disordered breathing manifests as 1) central hypoventilation that reflects impaired automatic control of ventilation secondary to degeneration of the pontomedullary respiratory centers; and, more commonly, as 2) stridor and obstructive sleep apnea due to larynx narrowing secondary to combined vocal cord abductor paralysis and excessive adductor activation during inspiration. Nocturnal stridor is a life-threatening condition in MSA associated with respiratory failure and sudden death during sleep. Long-term treatment with continuous positive airway pressure (CPAP) eliminates nocturnal stridor. Tracheostomy is advised when CPAP is not tolerated and stridor occurs during wakefulness.

Entities:  

Year:  2007        PMID: 17716598

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  22 in total

1.  The human pre-Bötzinger complex identified.

Authors:  Jan-Marino Ramirez
Journal:  Brain       Date:  2011-01       Impact factor: 13.501

2.  Sleep disorders in machado-joseph disease: frequency, discriminative thresholds, predictive values, and correlation with ataxia-related motor and non-motor features.

Authors:  José Luiz Pedroso; Pedro Braga-Neto; André Carvalho Felício; Lívia Almeida Dutra; William A C Santos; Gilmar Fernandes do Prado; Orlando Graziani Povoas Barsottini
Journal:  Cerebellum       Date:  2011-06       Impact factor: 3.847

3.  Sleep-Disordered Breathing in Multiple System Atrophy: Pathophysiology and New Insights for Diagnosis and Treatment.

Authors:  Rosalia Silvestri
Journal:  J Clin Sleep Med       Date:  2018-10-15       Impact factor: 4.062

4.  Degeneration of brainstem respiratory neurons in dementia with Lewy bodies.

Authors:  Michael F Presti; Ann M Schmeichel; Phillip A Low; Joseph E Parisi; Eduardo E Benarroch
Journal:  Sleep       Date:  2014-02-01       Impact factor: 5.849

Review 5.  The clinical approach to autonomic failure in neurological disorders.

Authors:  Eduardo E Benarroch
Journal:  Nat Rev Neurol       Date:  2014-05-27       Impact factor: 42.937

6.  Central hypoventilation in progressive supranuclear palsy.

Authors:  Kory S Herrick; Randy Woltjer; Thao Pham; Megan Chalupsky; Amie L Hiller
Journal:  Mov Disord Clin Pract       Date:  2016-05-19

Review 7.  Does the Type of Multisystem Atrophy, Parkinsonism, or Cerebellar Ataxia Impact on the Nature of Sleep Disorders?

Authors:  Luigi Ferini-Strambi; Sara Marelli; Romina Combi
Journal:  Curr Neurol Neurosci Rep       Date:  2016-12       Impact factor: 5.081

8.  The effects of sleep dysfunction on cognition, affect, and quality of life in individuals with cerebellar ataxia.

Authors:  Akshata Sonni; Lauri B F Kurdziel; Bengi Baran; Rebecca M C Spencer
Journal:  J Clin Sleep Med       Date:  2014-05-15       Impact factor: 4.062

9.  Sleep dysfunction in multiple system atrophy.

Authors:  Luigi Ferini-Strambi; Sara Marelli
Journal:  Curr Treat Options Neurol       Date:  2012-10       Impact factor: 3.598

10.  An autopsy report on multiple system atrophy diagnosed immunohistochemically despite severe ischaemic damage: a new approach for investigation of medical practice associated deaths in Japan.

Authors:  M Nakajima; H Kojima; Y Takazawa; N Yahagi; K Harada; K Takahashi; K Unuma; K Yoshida
Journal:  J Clin Pathol       Date:  2009-11       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.